'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.
about
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen ModificationCNS active O-linked glycopeptidesImmunological properties of gold nanoparticlesCarbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.Carbohydrate-Based Polymers for Immune ModulationLipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model.Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstruct.Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response.Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective.Gold nanoparticle conjugates: recent advances toward clinical applications.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Oral delivery of nanoparticle-based vaccines.Functional nanomaterials can optimize the efficacy of vaccines.Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.Multivalent Polymer Nanocomplex Targeting Endosomal Receptor of Immune Cells for Enhanced Antitumor and Systemic Memory Response.Antibody induction directed against the tumor-associated MUC4 glycoprotein.Iron oxide superparamagnetic nanoparticles conjugated with a conformationally blocked α-Tn antigen mimetic for macrophage activation.Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapy.Glyco-gold nanoparticles: synthesis and applications.Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination.In vitro and in vivo antitumor effects of 50 to 100-KDa components from B16 melanoma culture supernatant.Polymerization-induced self-assembly of galactose-functionalized biocompatible diblock copolymers for intracellular deliveryValency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.Multivalent Antimicrobial Polymer Nanoparticles Target Mycobacteria and Gram-Negative Bacteria by Distinct Mechanisms.Telechelic polymers from reversible-deactivation radical polymerization for biomedical applications.Glycopolymeric Materials for Advanced Applications.Inorganic nanoparticles as potential regulators of immune response in dendritic cells.Dual stimuli-responsive nano-vehicles for controlled drug delivery: mesoporous silica nanoparticles end-capped with natural chitosan.Aggregation behavior of pH- and thermo-responsive block copolymer protected gold nanoparticlesNew glycopolymers as multivalent systems for lectin recognitionMetal-assisted addition of a nitrate anion to bis(oxy)enamines. A general approach to the synthesis of α-nitroxy-oxime derivatives from nitronates
P2860
Q26748776-817972F3-8EA8-4596-9271-5AF0C6111A22Q27001592-AA35CEA4-90C5-4A75-83F9-80E967D12590Q27021529-FFC0D2F3-4D77-4662-8A07-D83274CEAD01Q33578950-216F39C7-D9B4-491F-A479-052516C67B90Q34478719-60572671-0FE8-480E-8C4A-AB1C6BBBA72FQ35212993-2B772160-DA6D-48F0-939C-29374625D944Q35705462-4920AF59-813B-46FB-9E79-59E4E1D63772Q35921552-29778A84-D51B-43F3-ACF2-7CD418AAB23EQ36202229-B6A00313-9424-4E7E-80B4-A84540E4B1BEQ36328299-2C70EEE2-4EB6-4783-9C63-40E897785C66Q36501284-34127635-9C9A-4E8F-AF9C-F446A22F8B8AQ36795032-08E9514B-AC97-4DC9-BCC8-D8E95F603D20Q37289629-7180D6D6-712B-413B-BC34-D96D76D97ABFQ37577596-BA5F47A2-4310-4D12-B42B-111F9A2067ADQ38180108-593EBC32-3444-493C-88FA-FE721BA7C5C1Q38190087-CB100D3B-5C8A-4BD4-A5C5-F4C26279F6FFQ38199152-EA05B613-B3BE-4028-9F0E-2B38311E79A4Q38243119-67B2541E-BA55-4770-963D-5D93354A4577Q38252639-30C72851-75A0-40F7-A27A-115E662F3DACQ38680785-AC87D99D-75FD-4065-A1AE-6F0B7CE9475CQ38870585-366BD974-90B4-4148-82EF-E85D223C2FCCQ38901814-C38C960D-65C0-419D-8D0B-60A39B545993Q38988340-3B55D7D9-B9EE-41C7-8FAA-784EB6DD31AAQ39012279-A2520C4E-C31C-4378-8111-D63E4BC8ACCCQ39013318-E5985330-A592-4183-A972-B869D7F176F0Q39419658-DDCFB650-99B5-4637-BAD2-72F7050A9039Q40943349-AB37746D-1B26-4D9C-AB9B-5D8D8FB3ABF3Q41550106-C75CF7F3-AD46-4D6B-BDB8-3F9EE67E3FBEQ42120198-39FD35F2-7A68-4E6D-A837-B84EB60A4225Q42534609-EFF172E8-0BB4-474D-9397-781C25CAFA9DQ46429495-A41DB028-6D39-433C-9263-887439C2B3BEQ48195066-DD8C29AC-362D-4665-AB2D-E7E3786E7DA4Q50053946-B82A66B0-7F6F-49D4-9620-F09C3EED7F71Q50295952-AAAEE304-347B-4229-B940-C7AF2CA83339Q50932486-FAE785B5-BD37-4A1D-A438-3FD17B0401B2Q53440698-6B5C4C8C-440C-4967-B96A-31CCDA16C04BQ57346604-21B366F1-1110-4899-962D-103231696D4CQ57368075-08115BDF-7875-4BF8-8EB5-52771A2BDE8FQ58365046-3B8A885A-4A81-4EA6-97A5-476F02502DE7
P2860
'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
'Multicopy multivalent' glycop ...... ial synthetic cancer vaccines.
@en
type
label
'Multicopy multivalent' glycop ...... ial synthetic cancer vaccines.
@en
prefLabel
'Multicopy multivalent' glycop ...... ial synthetic cancer vaccines.
@en
P2093
P2860
P356
P1476
'Multicopy multivalent' glycop ...... tial synthetic cancer vaccines
@en
P2093
Alison L Parry
Benjamin G Davis
James Ellis
Natasha A Clemson
P2860
P304
P356
10.1021/JA4046857
P407
P577
2013-06-17T00:00:00Z